Form 4: Select Medical EVP's Stock Transaction

Select Medical Holdings Corp. Executive Vice President Michael E. Tarvin reported the surrender of 19,640 shares of common stock to cover tax obligations related to restricted stock vesting.

Summary

• Michael E. Tarvin, Executive Vice President of Select Medical Holdings Corp. (SEM), reported a transaction involving company common stock.
• On August 1, 2025, 19,640 shares of common stock were surrendered.
• This surrender was to satisfy tax withholding obligations incident to the vesting of restricted stock.
• The shares were valued at $12.57 per share for this transaction.
• Following this transaction, Mr. Tarvin beneficially owns 508,120 shares of Select Medical Holdings Corp. common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine tax-related disposition of shares upon restricted stock vesting, which is a neutral event for company operations and stock valuation.

Positives

• The vesting of restricted stock indicates that performance conditions (if any) were met, and the executive is receiving compensation.
• The executive retains a significant beneficial ownership of 508,120 shares, aligning interests with shareholders.

Negatives

• A reduction in the executive's direct shareholding, albeit for tax purposes.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The surrender of shares for tax purposes is a common event and does not significantly impact shareholder value. It confirms the vesting of executive compensation.

Key Dates

Recommendation

The filing details a routine tax-related disposition of shares by an executive upon the vesting of restricted stock. This type of transaction is a standard part of executive compensation and does not indicate any fundamental change in the company's operations, financial health, or strategic direction that would warrant a change in investment recommendation. The executive retains a substantial beneficial ownership, aligning their interests with shareholders.

Keywords

Select Medical, SEM, Form 4, Insider Transaction, Stock, Executive, Michael Tarvin, Restricted Stock, Tax Withholding